BlackRock Group’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$176K Buy
216
+125
+137% +$99.2K ﹤0.01% 2696
2016
Q3
$83K Hold
91
﹤0.01% 2848
2016
Q2
$81K Hold
91
﹤0.01% 2835
2016
Q1
$47K Buy
91
+56
+160% +$28.5K ﹤0.01% 2933
2015
Q4
$21K Hold
35
﹤0.01% 2934
2015
Q3
$23K Buy
+35
New +$26.6K ﹤0.01% 2962
2015
Q1
Sell
-8
Closed -$14K 2891
2014
Q4
$14K Hold
8
﹤0.01% 2840
2014
Q3
$12K Buy
+8
New +$14.5K ﹤0.01% 2794
2014
Q2
Sell
-201
Closed -$368K 2871
2014
Q1
$368K Buy
201
+111
+123% +$258K ﹤0.01% 2326
2013
Q4
$239K Buy
+90
New +$177K ﹤0.01% 2389

Other funds holding VIVS

BlackRock Group's VIVS Position: Q4 2016 in Review

BlackRock Group increased its VivoSim Labs (VIVS) stake by 137% in Q4 2016, buying an estimated $99.2K and bringing the position to 216 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

BlackRock Group first reported a position in VIVS in Q4 2013 and has held it in 10 quarters since. The position peaked at $368K in Q1 2014. 128 funds tracked by Wall St. Rank hold VIVS as of Q4 2016.

  • BlackRock Group held 216 shares of VivoSim Labs worth $176K as of Q4 2016.
  • BlackRock Group bought 125 VivoSim Labs shares in Q4 2016, an estimated $99.2K.
  • VivoSim Labs made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2696 holding.
  • BlackRock Group first reported a position in VivoSim Labs in Q4 2013 and has held it in 10 quarters since.
  • BlackRock Group's VivoSim Labs position peaked at $368K in Q1 2014.
  • 128 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.